Pheochromocytoma - An approach to antihypertensive management

被引:40
作者
Bravo, EL [1 ]
机构
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源
ENDOCRINE HYPERTENSION | 2002年 / 970卷
关键词
pheochromocytoma; high plasma catecholamine levels; hypertension; antihypertensive agents; sympathetic nervous system; neuropeptide Y (NPY) levels;
D O I
10.1111/j.1749-6632.2002.tb04408.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pheochromocytoma and paragangliomas are rare tumors of chromaffin tissue that secrete catecholamines either intermittently or continuously, producing hypertension with a constellation of symptoms and signs that can be frightening to the patient and that continue to provide perplexing problems for clinicians. With surgical treatment, symptoms will be relieved and hypertension normalized or ameliorated for patients who do not have malignant tumors. Appropriate antihypertensive drugs are used to manage hypertension, to control associated cardiovascular symptoms, and to prepare patients for operation. The question debated most often regarding medical therapy of pheochromocytoma is whether antihypertensive treatment regimens other than nonspecific alpha-blockade are just as effective and safe. Understanding the pathophysiologic mechanisms that sustain the hypertension and the pharmacology of antihypertensive agents allows better selection of antihypertensive therapy.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 31 条
[11]   NIFEDIPINE IN PHEOCHROMOCYTOMA [J].
FAVRE, L ;
VALLOTTON, MB .
ANNALS OF INTERNAL MEDICINE, 1986, 104 (01) :125-125
[12]   RECOVERY INVIVO AND INVITRO OF ALPHA-ADRENOCEPTOR RESPONSES AND RADIOLIGAND BINDING AFTER PHENOXYBENZAMINE [J].
HAMILTON, C ;
DALRYMPLE, H ;
REID, J .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 :S125-S128
[13]   ACUTE EFFECTS OF PHENOXYBENZAMINE ON ALPHA-ADRENOCEPTOR RESPONSES INVIVO AND INVITRO - RELATION OF INVIVO PRESSOR-RESPONSES TO THE NUMBER OF SPECIFIC ADRENOCEPTOR BINDING-SITES [J].
HAMILTON, CA ;
REID, JL ;
SUMNER, DJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (05) :868-873
[14]   CLONED HUMAN NEUROPEPTIDE-Y RECEPTOR COUPLES TO 2 DIFFERENT 2ND MESSENGER SYSTEMS [J].
HERZOG, H ;
HORT, YJ ;
BALL, HJ ;
HAYES, G ;
SHINE, J ;
SELBIE, LA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (13) :5794-5798
[15]  
Hoffman BB., 2001, GOODMAN GILMANS PHAR, V10th, P215
[16]  
JOHNSON MD, 1999, J PHARMACOL EXP THER, V227, P254
[17]   RECENT DEVELOPMENTS IN NORADRENERGIC NEUROTRANSMISSION AND ITS RELEVANCE TO THE MECHANISM OF ACTION OF CERTAIN ANTIHYPERTENSIVE AGENTS [J].
LANGER, SZ ;
CAVERO, I ;
MASSINGHAM, R .
HYPERTENSION, 1980, 2 (04) :372-382
[18]  
LEHMANN HU, 1983, HYPERTENSION, V5, P66
[19]   TREATMENT OF A PHEOCHROMOCYTOMA OF THE URINARY-BLADDER WITH NIFEDIPINE [J].
LENDERS, JWM ;
SLUITER, HE ;
THIEN, T ;
WILLEMSEN, J .
BRITISH MEDICAL JOURNAL, 1985, 290 (6482) :1624-1625
[20]   NEUROPEPTIDE Y-LIKE IMMUNOREACTIVITY IN ADRENALINE CELLS OF ADRENAL-MEDULLA AND IN TUMORS AND PLASMA OF PHEOCHROMOCYTOMA PATIENTS [J].
LUNDBERG, JM ;
HOKFELT, T ;
HEMSEN, A ;
THEODORSSONNORHEIM, E ;
PERNOW, J ;
HAMBERGER, B ;
GOLDSTEIN, M .
REGULATORY PEPTIDES, 1986, 13 (02) :169-182